Cargando…

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System

A dysregulated immune response with hyperinflammation is observed in patients with severe coronavirus disease 2019 (COVID-19). The aim of the present study was to assess the safety and potential benefits of human recombinant C1 esterase inhibitor (conestat alfa), a complement, contact activation and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urwyler, Pascal, Moser, Stephan, Charitos, Panteleimon, Heijnen, Ingmar A. F. M., Rudin, Melanie, Sommer, Gregor, Giannetti, Bruno M., Bassetti, Stefano, Sendi, Parham, Trendelenburg, Marten, Osthoff, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456998/ https://www.ncbi.nlm.nih.gov/pubmed/32922409 http://dx.doi.org/10.3389/fimmu.2020.02072

Ejemplares similares

Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
por: Urwyler, Pascal, et al.
Publicado: (2021)

Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study
por: Charitos, Panteleimon, et al.
Publicado: (2021)

Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression
por: Urwyler, Pascal, et al.
Publicado: (2022)

Conestat alfa for the treatment of angioedema attacks
por: Davis, Benjamin, et al.
Publicado: (2011)

Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial
por: Urwyler, Pascal, et al.
Publicado: (2023)

Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation
por: Lopatko Fagerström, Ingrid, et al.
Publicado: (2019)

Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study
por: Bruni, Flavio, et al.
Publicado: (2022)

Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation
por: Bekassy, Zivile, et al.
Publicado: (2021)

The kallikrein-kinin system in diabetic nephropathy
por: Tomita, Hirofumi, et al.
Publicado: (2012)

Kallikrein–kinin system: is it the fountain of youth?
por: Garaffa, Giulio, et al.
Publicado: (2017)

Home treatment with conestat alfa in attacks of hereditary angioedema due to C1-inhibitor deficiency
por: Farkas, Henriette, et al.
Publicado: (2015)

Role of the kallikrein–kinin system in traumatic brain injury
por: Albert-Weissenberger, Christiane, et al.
Publicado: (2014)

Lack of Plasma Kallikrein-Kinin System Cascade in Teleosts
por: Wong, Marty Kwok-Shing, et al.
Publicado: (2013)

Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study
por: Osthoff, Michael, et al.
Publicado: (2019)

Interaction of Bacteroides fragilis and Bacteroides thetaiotaomicron with the kallikrein–kinin system
por: Murphy, Elizabeth C., et al.
Publicado: (2011)

Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity
por: Alfaro, Enrique, et al.
Publicado: (2022)

In vitro reconstitution of kallikrein-kinin system and progress curve analysis
por: Favier, Bertrand, et al.
Publicado: (2022)

Editorial: Kallikrein-kinin system: insights into a multifunctional system
por: Motta, Guacyara, et al.
Publicado: (2023)

A Trial of Complement Inhibition in a Patient with Cryoglobulin-Induced Glomerulonephritis
por: Hirt-Minkowski, Patricia, et al.
Publicado: (2012)

The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection
por: Carvalho, Patricia Ribeiro de, et al.
Publicado: (2021)

COVID-19 and Lung Mast Cells: The Kallikrein–Kinin Activation Pathway
por: Nagashima, Seigo, et al.
Publicado: (2022)

Alterations in the kallikrein-kinin system predict death after heart transplant
por: Giangreco, Nicholas P., et al.
Publicado: (2022)

The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor
por: Panagiotou, Anneza, et al.
Publicado: (2018)

The kallikrein-kinin system: a promising therapeutic target for traumatic brain injury
por: Hopp, Sarah, et al.
Publicado: (2015)

Genetic Variation of Kallikrein-Kinin System and Related Genes in Patients With Hereditary Angioedema
por: Veronez, Camila Lopes, et al.
Publicado: (2019)

Modulation of the Plasma Kallikrein-Kinin System Proteins Performed by Heparan Sulfate Proteoglycans
por: Motta, Guacyara, et al.
Publicado: (2017)

The relationship between clinical phenotype and kallikrein-kinin bioregulation in different forms of arthritis
por: Tan, Dino B. A., et al.
Publicado: (2023)

Anti-C1q Antibodies as a Follow-Up Marker in SLE Patients
por: Bock, Merete, et al.
Publicado: (2015)

Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on‐demand treatment of hereditary angioedema
por: Duckworth, Edward J., et al.
Publicado: (2022)

A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin–Angiotensin Systems
por: Schmaier, Alvin H.
Publicado: (2016)

The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model
por: da Costa, Patricia Luiza Nunes, et al.
Publicado: (2018)

Pharmacologic Targets and Prototype Therapeutics in the Kallikrein-Kinin System: Bradykinin Receptor Agonists or Antagonists
por: Sharma, J. N., et al.
Publicado: (2006)

AB097. The expression of kallikrein-kinin system in penile tissue of ED rat model
por: Amuti, Siyiti, et al.
Publicado: (2018)

The kallikrein–kinin pathway as a mechanism for auto-control of brown adipose tissue activity
por: Peyrou, Marion, et al.
Publicado: (2020)

Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome
por: van de Veerdonk, Frank L, et al.
Publicado: (2020)

Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19
por: Mansour, Eli, et al.
Publicado: (2021)

Targeted LC-MS/MS platform for the comprehensive determination of peptides in the kallikrein-kinin system
por: Gangnus, Tanja, et al.
Publicado: (2021)

Sensitive mass spectrometric determination of kinin-kallikrein system peptides in light of COVID-19
por: Gangnus, Tanja, et al.
Publicado: (2021)

Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19
por: Martens, Caroline P., et al.
Publicado: (2022)

Glycated albumin modulates the contact system with implications for the kallikrein-kinin and intrinsic coagulation systems
por: Hardy, Lewis J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_csuro2d9j0p30lccms4p2aq9vu